<DOC>
	<DOCNO>NCT00061789</DOCNO>
	<brief_summary>This study use single photon emission compute tomography ( SPECT ) study brain nicotine receptor ( protein surface brain cell ) healthy subject patient schizophrenia . Autopsy find patient schizophrenia show change nicotine receptor . This study use SPECT look receptor live schizophrenia patient compare healthy subject . The following individual 21 50 year age ( 21 80 year age Group 1 ) eligible study : healthy non-smokers ( Group 1 ) ; schizophrenia patient smoke ( Group 2 ) ; schizophrenia patient smoke ( Group 3 ) ; healthy smoker ( Group 4 ) ; healthy non-smokers ( Group 5 ) . Patients schizophrenia must take olanzapine ( Zyprexa ) risperidone ( Risperdal ) least 6 month . All candidate screen first visit . Group 1 participant three visit ; Groups 2 5 two visit . Visit 1 All participant screen physical neurological examination ; blood urine test ; neuropsychological test assess ability learn remember word number , pay attention , quickly perform motor task , put pegs piece wood . In addition , eye movement test event-related potential testing . For eye test , subject sits chair lean forward chin chin rest . A band tie around head small amount invisible ( infrared ) light shin eye . The light reflect back measure . Wire electrodes place around area eye cheek monitor eye blink eye movement . Subjects ask follow light eye look away light . For event- related potential testing , electrode place scalp , forehead cheek , brain activity record subject identifies particular picture sound . Visit 2 ( Visit 3 Group 1 ) Participants SPECT scan . On night scan , day scan , 4 day scan , subject take oral dose potassium iodide protect thyroid gland radioactive tracer use SPECT procedure . ( Individuals allergic potassium iodide take potassium perchlorate instead . ) For SPECT scan , small radioactive marker contain 99mTc glue subject 's head . Two catheter ( thin , flexible tube ) place vein arm inject radioactive tracer [ 123I ] 5-I-A-85380 draw blood sample . During scan , subject lie bed head hold still headholder . The scan take 9-hour period injection tracer injection . An electrocardiogram , respiration , blood pressure measure take injection [ 123I ] 5-I-A-85380 , 5 minute injection , 30 60 minute injection . Breath sample collect every 60 minute . Blood urine sample collect 5 6 hour start scan . Group 1 subject second SPECT scan within 4 week first . Visit 3 ( Visit 4 Group 1 ) Participants magnetic resonance imaging ( MRI ) scan . For procedure , subject lie table slide narrow metal cylinder strong magnetic field scan . The scanner use magnetic field radio wave produce image show structural chemical change tissue . The test last 1 hour .</brief_summary>
	<brief_title>Imaging Brain Receptors Healthy Volunteers Patients With Schizophrenia</brief_title>
	<detailed_description>Abnormalities nicotinic acetylcholine system schizophrenia imply high prevalence cigarette smoking . Because animal human study show nicotinic acetylcholine receptor ( nAChRs ) play important role cognitive function , cognitive deficit schizophrenia also suggest abnormality receptor . Postmortem study show abnormality high affinity nAChRs patient direction abnormality ( increase decrease ) consistent probably difficult control effect cigarette smoke neuroleptic study . In vivo imaging study necessary study relationship nAChRs psychiatric symptom include cognitive impairment . We plan use new single photon emission compute tomography ( SPECT ) tracer , [ ( 123 ) I ] 5-I-A-85380 , appear suitable image high affinity Alpha 4 Beta 2 subtype nAChRs . We plan compare four group , 1 ) schizophrenia smoker , 2 ) schizophrenia non-smokers , 3 ) healthy smoker , 4 ) healthy non-smokers . All patient stable dos olanzapine risperidone . In addition compare [ ( 123 ) I ] 5-I-A-85380 binding among group , relationship study psychiatric symptom cognitive dysfunction SPECT measurement receptor . Further , study reliability SPECT measurement , test retest study preform healthy subject wide range . The propose study explore role nAChRs psychiatric symptom , particularly cognitive deficit schizophrenia , central impairment disorder . New finding research lead enhance treatment cognitive deficit .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<criteria>INCLUSION CRITERIA : ControlsGroup 1 : Healthy Diagnosis ; 2180 year ; No Cigarette Smoking ; Plasma Cotinine le 3 ng/mL ; No olanzapine risperidone Smoker PatientsGroup 2 : Diagnosis Schizophrenia ; 2150 year ; Cigarette Smoking great 20 per day great 5 year ; Plasma Cotinine great 100 ng/mL ; Olanzapine risperidone great 6 mo . dose 2 week NonSmoker PatientsGroup 3 : Diagnosis Schizophrenia ; 2150 year ; No Cigarette Smoking ; Plasma Cotinine le 3 ng/mL ; Olanzapine risperidone great 6 mo . dose 2 week Smoker ControlsGroup 4 : Healthy Diagnosis ; 2150 year ; Cigarette Smoking great 20 per day great 5 year ; Plasma Cotinine great 100 ng/mL ; No olanzapine risperidone NonSmoker ControlsGroup 5 : Healthy Diagnosis ; 2150 year ; No Cigarette Smoking ; Plasma Cotinine le 3 ng/mL ; No olanzapine risperidone</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2004</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>SPECT</keyword>
	<keyword>Nicotinic Acetylcholine Receptors</keyword>
	<keyword>Cigarette Smoking</keyword>
	<keyword>Cognitive Dysfunction</keyword>
	<keyword>Reproducibility</keyword>
	<keyword>Quantification</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>